Wednesday, 11 January 2012

Memantine study: no effect on dementia in people with Down syndrome

The report from a UK study of  the drug memantine (Nemanda) as a treatment for Alzheimer's disease in people with Down syndrome has shown no significant effects.

Read the news report and commentary in Family Practice News here.

Adult Down Syndrome Clinic comments and link to to the abstract of the research report published in the The Lancet.

If you need information about people with Down syndrome and Alzheimer's disease in Australia, you are welcome to visit our web pages on Growing Older with Down Syndrome for information, links and contact details for our support staff.

No comments: